rs587777138
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001382391.1(CSPP1):c.2335C>T(p.Arg779Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000149 in 1,610,368 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001382391.1 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CSPP1 | NM_001382391.1 | c.2335C>T | p.Arg779Ter | stop_gained | 20/31 | ENST00000678616.1 | NP_001369320.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CSPP1 | ENST00000678616.1 | c.2335C>T | p.Arg779Ter | stop_gained | 20/31 | NM_001382391.1 | ENSP00000504733 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 151738Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000365 AC: 9AN: 246274Hom.: 0 AF XY: 0.0000299 AC XY: 4AN XY: 133720
GnomAD4 exome AF: 0.0000123 AC: 18AN: 1458630Hom.: 0 Cov.: 30 AF XY: 0.0000110 AC XY: 8AN XY: 725620
GnomAD4 genome AF: 0.0000395 AC: 6AN: 151738Hom.: 0 Cov.: 32 AF XY: 0.0000405 AC XY: 3AN XY: 74106
ClinVar
Submissions by phenotype
Joubert syndrome 21 Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 28, 2023 | This sequence change creates a premature translational stop signal (p.Arg774*) in the CSPP1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CSPP1 are known to be pathogenic (PMID: 24360807, 24360808). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 100666). This premature translational stop signal has been observed in individual(s) with Joubert syndrome and Jeune asphyxiating thoracic dystrophy (JATD) (PMID: 24360808). This variant is present in population databases (no rsID available, gnomAD 0.03%). - |
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Aug 19, 2020 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Jan 02, 2014 | - - |
CSPP1-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 20, 2024 | The CSPP1 c.2320C>T variant is predicted to result in premature protein termination (p.Arg774*). This variant has been reported in the homozygous state in an individual with Joubert syndrome (Tuz et al. 2014. PubMed ID: 24360808). This variant is reported in 0.026% of alleles in individuals of Latino descent in gnomAD. Nonsense variants in CSPP1 are expected to be pathogenic. This variant is interpreted as pathogenic. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Feb 25, 2024 | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 24360808) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at